Profil
Abdullah bin Turki bin Saad Al-Sudairy is the Chief Executive Officer at Amlak International for Real Estate Financing since 2014 and has been with the company since 2007.
Former positions include Independent Director at Saudi Ceramic Co. and Dallah Healthcare Co., and Assistant GM-Corporate Division at Samba Financial Group from 1999 to 2007.
Education includes a graduate degree from Thunderbird School of Global Management conferred in 1996 and an undergraduate degree from King Saud University.
Aktive Positionen von Abdullah Al-Sudairy
| Unternehmen | Position | Beginn |
|---|---|---|
| AMLAK INTERNATIONAL FINANCE COMPANY | Vorstandsvorsitzender | 01.01.2014 |
Ehemalige bekannte Positionen von Abdullah Al-Sudairy
| Unternehmen | Position | Ende |
|---|---|---|
| SAMBA FINANCIAL GROUP | Corporate Officer/Principal | 01.01.2007 |
| DALLAH HEALTHCARE COMPANY | Direktor/Vorstandsmitglied | - |
| SAUDI CERAMIC COMPANY | Direktor/Vorstandsmitglied | - |
Ausbildung von Abdullah Al-Sudairy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Samba Financial Group
Samba Financial Group Regional BanksFinance Provides commercial banking services | Finance |
Thunderbird School of Global Management
Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saudi Ceramic Co.
Saudi Ceramic Co. Building ProductsProducer Manufacturing Manufactures ceramic tiles, fixtures, and electric water heaters | Producer Manufacturing |
King Saud University
King Saud University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amlak International for Real Estate Financing
Amlak International for Real Estate Financing Provides real estate financing services | |
Dallah Healthcare Co.
Dallah Healthcare Co. Operates as a holding company with interest in hospital and pharmaceutical industries |
















